All Satellite Symposia, Presentation Theaters, and Learning Lounges preceding and following the official program IDWeek 2016 are independently organized and executed. IDWeek does not endorse or support the programming of any Symposia, Presentation Theater, or Learning Lounge.
CDC’s Advisory Committee on Immunization Practices (ACIP) recommendations for adult pneumococcal vaccination
Identifying adult patients for pneumococcal vaccination in various treatment settings
Kerry O. Cleveland, MD, FIDSA
Professor of Medicine
University of Tennessee Health Science Center, Memphis
Methodist University Hospital
Michael D. Hogue, Pharm.D., FAPhA, FNAP
Associate Dean, Center for Faith and Health
Professor of Pharmacy
College of Health Sciences
Learning Lounge Summary
The Healthy People 2020 program set an objective to increase the percentage of adults aged 65+ who are vaccinated against pneumococcal disease to 90% by 2020. Adult vaccination rates against pneumococcal disease continue to fall short of this goal. Improving adult vaccination rates in the United States is a responsibility shared by all healthcare providers. This presentation will provide an overview of the CDC’s ACIP recommendations for pneumococcal vaccination in older adults, as well as review selected scenarios in which appropriate patients can be identified as candidates for vaccination.